Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.17
$0.087.34%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 8.95% | 8.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 8.95% | 8.95% |
| Cost of Revenue | -- | -- | -- | 1.36% | 1.36% |
| Gross Profit | -- | -- | -- | 13.95% | 13.95% |
| SG&A Expenses | -- | -- | -- | 12.47% | 12.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | 290.52% | 290.52% |
| Total Operating Expenses | -- | -- | -- | 7.99% | 7.99% |
| Operating Income | -- | -- | -- | 12.97% | 12.97% |
| Income Before Tax | -- | -- | -- | 4.31% | 4.31% |
| Income Tax Expenses | -- | -- | -- | -0.87% | -0.87% |
| Earnings from Continuing Operations | -- | -- | -- | 7.15% | 7.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | 2.43% | 2.43% |
| EBIT | -- | -- | -- | 12.97% | 12.97% |
| EBITDA | -- | -- | -- | 12.92% | 12.92% |
| EPS Basic | -- | -- | -- | 6.80% | 6.80% |
| Normalized Basic EPS | -- | -- | -- | 9.21% | 9.21% |
| EPS Diluted | -- | -- | -- | 6.80% | 6.80% |
| Normalized Diluted EPS | -- | -- | -- | 9.21% | 9.21% |
| Average Basic Shares Outstanding | -- | -- | -- | -4.16% | -4.16% |
| Average Diluted Shares Outstanding | -- | -- | -- | -4.16% | -4.16% |
| Dividend Per Share | -- | -- | -- | -15.85% | -15.85% |
| Payout Ratio | -- | -- | -- | 0.46% | 0.46% |